Curiox Biosystems Co., Ltd (KOSDAQ:445680)
South Korea · Delayed Price · Currency is KRW 68,900
-500 (-0.72%)
At close: Jun 12, 2026
Curiox Biosystems Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -26,200 | -27,177 | -8,089 | -10,040 | -11,495 | -14,524 |
Depreciation & Amortization | 2,838 | 2,873 | 2,578 | 1,952 | 1,598 | 1,236 |
Loss (Gain) From Sale of Assets | 68.53 | 68.44 | 123.27 | -13.02 | 12.11 | - |
Asset Writedown & Restructuring Costs | 423.21 | 423.21 | - | - | - | 84.1 |
Stock-Based Compensation | 1,067 | 992.87 | 777.17 | -8.84 | 678.35 | 613.76 |
Provision & Write-off of Bad Debts | 13.15 | 25.72 | 2.14 | 17.29 | 1.88 | 12.66 |
Other Operating Activities | 13,983 | 14,551 | -5,163 | -334.89 | 301.64 | 7,214 |
Change in Accounts Receivable | -43.02 | -1,436 | 2,737 | 227.68 | 1,212 | 75.22 |
Change in Inventory | -1,343 | -1,482 | -458.81 | 195.89 | -829.5 | -1,163 |
Change in Accounts Payable | -153.52 | 157.28 | -1,196 | -688.69 | -1,509 | 809.8 |
Change in Other Net Operating Assets | 331.98 | -107.24 | -1,009 | 528.91 | 140.75 | 516.07 |
Operating Cash Flow | -9,015 | -11,109 | -9,698 | -8,164 | -9,888 | -5,126 |
Capital Expenditures | -137.84 | -136.1 | -257.88 | -211.53 | -822.86 | -261.26 |
Sale of Property, Plant & Equipment | - | - | - | 1.79 | - | - |
Sale (Purchase) of Intangibles | - | - | - | - | -17.9 | - |
Investment in Securities | 7,411 | 1,000 | -4,000 | 3,125 | 5,691 | -8,007 |
Other Investing Activities | 39.72 | 55.87 | -16.81 | -16.69 | -116.92 | -43.25 |
Investing Cash Flow | 7,313 | 919.77 | -4,275 | 2,898 | 4,734 | -8,311 |
Long-Term Debt Issued | - | - | 19,998 | - | - | - |
Long-Term Debt Repaid | - | -412.19 | -397.16 | -320.22 | -236.66 | -93.69 |
Net Debt Issued (Repaid) | -406.09 | -412.19 | 19,600 | -320.22 | -236.66 | -93.69 |
Issuance of Common Stock | 733.42 | 806.96 | 260.9 | 17,964 | - | - |
Other Financing Activities | - | - | 0 | -0 | - | 13,087 |
Financing Cash Flow | 327.33 | 394.77 | 19,861 | 17,644 | -236.66 | 16,999 |
Foreign Exchange Rate Adjustments | 109.43 | 392.46 | 390.05 | -65.54 | -15.47 | 397.85 |
Miscellaneous Cash Flow Adjustments | -0 | - | -0 | - | - | - |
Net Cash Flow | -1,266 | -9,402 | 6,279 | 12,312 | -5,407 | 3,960 |
Free Cash Flow | -9,153 | -11,245 | -9,956 | -8,376 | -10,711 | -5,387 |
Free Cash Flow Margin | -164.78% | -218.29% | -217.02% | -123.39% | -148.00% | -97.54% |
Free Cash Flow Per Share | -545.80 | -680.75 | -619.10 | -585.95 | -1509.32 | -413.36 |
Cash Interest Paid | 20.94 | 22.74 | 34.68 | 25.7 | 29.23 | 9.35 |
Cash Income Tax Paid | - | 11.92 | 50.11 | 11.81 | 16.14 | -3.84 |
Levered Free Cash Flow | -12,441 | -14,077 | 3,490 | -3,723 | -8,886 | -4,602 |
Unlevered Free Cash Flow | -11,890 | -13,334 | 3,929 | -3,707 | -7,150 | -3,537 |
Change in Working Capital | -1,208 | -2,867 | 72.97 | 263.79 | -985.77 | 238.26 |